Cargando…
Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification
Objective: We aim at investigating the molecular mechanisms through which the Qingfei Jiedu decoction (QFJDD) regulates PD-L1 expression in lung adenocarcinoma (LUAD). Methods: Bioactive compounds and targets of QFJDD were screened from TCMSP, BATMAN-TCM, and literature. Then, GeneCard, OMIM, PharmG...
Autores principales: | Pan, Junjie, Yang, Hongkuan, Zhu, Lihong, Lou, Yafang, Jin, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454399/ https://www.ncbi.nlm.nih.gov/pubmed/36091822 http://dx.doi.org/10.3389/fphar.2022.897966 |
Ejemplares similares
-
Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application
por: Ren, Wei, et al.
Publicado: (2021) -
Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury
por: Liu, Jiahui, et al.
Publicado: (2023) -
Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19
por: Li, Liyuan, et al.
Publicado: (2022) -
Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis
por: Wang, Qi, et al.
Publicado: (2021) -
Decoding the Mechanism of Huanglian Jiedu Decoction in Treating Pneumonia Based on Network Pharmacology and Molecular Docking
por: Li, Xianhai, et al.
Publicado: (2021)